Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
N/A
-461,609 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
N/A
461,609 New
461,609 $974,000
Q1 2021

May 17, 2021

SELL
N/A
-57,097 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
N/A
44,523 Added 354.09%
57,097 $122,000
Q3 2020

Nov 16, 2020

SELL
N/A
-4,050 Reduced 24.36%
12,574 $78,000
Q2 2020

Aug 14, 2020

BUY
N/A
16,624 New
16,624 $107,000
Q3 2019

Nov 14, 2019

SELL
N/A
-21,118 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
N/A
-51,206 Reduced 70.8%
21,118 $170,000
Q1 2019

May 14, 2019

BUY
N/A
72,324 New
72,324 $573,000

About Catabasis Pharmaceuticals, Inc.


  • Ticker CATB
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,948,800
  • Market Cap $657M
More about CATB
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.